European Cannabis Corporation Ltd (“Eurocann”) is an Australian, unlisted public company with extensive connections into the global medical cannabis sector. It owns 100% of the HAPA Pharm Group in Germany that was established by a group of seasoned German executives specifically to take advantage of the 2017 changes in German legislation allowing for medicinal cannabis to become available to patients.
https://www.europeancannabiscorp.com/HAPA is an early mover in this market and is rapidly building a vertically integrated business where it has activities across the spectrum from cultivation, manufacturing and distribution of its medical products (both CBD-only as well as those containing THC). It also conducts medical outreach/education programmes to physicians and patients as well as certain clinical trial activities.
https://www.hapa-pharm.com/
